Coordinatore | AXIO CONSULTING AS
Organization address
address: ST. OLAVS PLASS 3 contact info |
Nazionalità Coordinatore | Norway [NO] |
Totale costo | 1˙587˙512 € |
EC contributo | 1˙244˙000 € |
Programma | FP7-SME
Specific Programme "Capacities": Research for the benefit of SMEs |
Code Call | FP7-SME-2012 |
Funding Scheme | BSG-SME |
Anno di inizio | 2013 |
Periodo (anno-mese-giorno) | 2013-01-01 - 2014-12-31 |
# | ||||
---|---|---|---|---|
1 |
AXIO CONSULTING AS
Organization address
address: ST. OLAVS PLASS 3 contact info |
NO (OSLO) | coordinator | 621˙354.90 |
2 |
HALLMARK ELECTRONICS LIMITED
Organization address
address: LOOMER ROAD HALLMARK HOUSE contact info |
UK (NEWCASTLE UNDER LYME) | participant | 331˙599.53 |
3 |
REEVITE INDUSTRIAL MOULDINGS LTD
Organization address
address: MURDOCK ROAD BICESTER 16 contact info |
UK (HEREFORD) | participant | 141˙066.20 |
4 |
INRAY SOLUTIONS LTD
Organization address
address: MLADOST 3 COMPLEX BL 302 ENT 4 FL 1 AP 47 contact info |
BG (SOFIA) | participant | 118˙683.37 |
5 |
SORLANDET SYKEHUS HF
Organization address
address: EGSVEIEN 100 contact info |
NO (KRISTIANSAND S) | participant | 13˙600.00 |
6 |
JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH
Organization address
address: LEONHARDSTRASSE 59 contact info |
AT (GRAZ) | participant | 9˙637.00 |
7 |
OSAUHING EESTI INNOVATSIOONI INSTITUUT
Organization address
address: SEPAPAJA 6 contact info |
EE (TALLINN) | participant | 8˙059.00 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'Ischemic Heart Disease (IHD) and its direct consequences is the number one cause of death in high income and middle income countries such as EU countries and the number four cause of death in low income countries; in 2008, IHD caused 7.25Mn deaths globally and a little over 1Mn in the European Region. In addition, IHD is the second leading cause of burden of disease (as measured in Disability-Adjusted Life Years or DALYs, or years of lost healthy life) in the high and middle income countries and number nine in low income countries; in the European Region, IHD is the number one cause of disease burden. Between 70% to 90% of the episodes of IHD that can be detected with ECG are clinically silent, with patients unable to report symptoms like chest pain or discomfort. Currently, if an out-patient is suspected to have IHD, he or she is referred to the “stress test” Stress test is relatively expensive in Europe (€3,000 – 4,000 per procedure), requires qualified medical assistance during preparation, testing and result interpretation and has a long waiting period (3 to 6 months). Critical in-patients are normally monitored with the continuous 12 lead ECG for 24-48 hours in the hospital in an even more expensive procedure.
We propose to develop a novel wireless product for preventive screening and monitoring of IHD that is able to monitor patient’s ECG during daily activities over a 24 to 48 hour period with quality of the SoA 12 lead ECG unit as a new type of ambulatory ECG that would cost less than 20% of the stress test. Innovative approaches are to include a truly wireless solution for patient convenience, patient positional information, information of breathing activity and tissue oxygenation as the need for automatic adjustment of continuous ECG signal for patient’s orientation during the cardiac cycle and adjustment for types of physical activity and irregular heartbeats have become the requirement by the medical community.'
Novel plasma-catalyst reactor for the total conversion of the ammonia contained in pig manure into environmental neutral products
Read More"AN OPEN LINKED DATA PLATFORM FOR SEMANTICALLY-INTERCONNECTING ONLINE, SOCIAL MEDIA LEVERAGING THE CORPORATE BRAND AND MARKET SECTOR REPUTATION ANALYSIS AND RESPONSE OPTIMIZATION SERVICES"
Read More